Global Cord Blood Corp.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG393421030
USD
1.00
1 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
No of Months
12
12
12
12
12
12
Operating Income
193.00
171.00
175.00
147.00
141.00
112.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
193.00
171.00
175.00
147.00
141.00
112.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
17.00
General and Administration Expenses
64.00
58.00
62.00
57.00
67.00
52.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
98.00
90.00
95.00
90.00
99.00
77.00
Operating Profit (PBDIT) excl Other Income
94.00
80.00
80.00
56.00
42.00
35.00
Other Income
6.00
5.00
4.00
4.00
4.00
7.00
Operating Profit (PBDIT)
108.00
93.00
92.00
69.00
53.00
50.00
Interest
0.00
0.00
0.00
0.00
0.00
17.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
7.00
7.00
7.00
7.00
7.00
7.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
97.00
90.00
83.00
53.00
45.00
24.00
Provision for Tax
18.00
13.00
14.00
9.00
9.00
5.00
Profit After Tax
78.00
74.00
67.00
43.00
35.00
17.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.64
0.62
0.56
0.36
0.30
0.24
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2022 is 13.27% vs -2.44% in Mar 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2022 is 18.06% vs 0.15% in Mar 2021

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2022 is 4.16% vs 10.95% in Mar 2021

Compare Profit and Loss Results of Global Cord Blood Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
193.00
0
193.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
193.00
0
193.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
64.00
0
64.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
98.00
0
98.00
0%
Operating Profit (PBDIT) excl Other Income
94.00
0.00
94.00
0%
Other Income
6.00
0
6.00
0%
Operating Profit (PBDIT)
108.00
0
108.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
7.00
0
7.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
97.00
0
97.00
0%
Provision for Tax
18.00
0
18.00
0%
Profit After Tax
78.00
0
78.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.6424
0
0.64
0%
Profit And Loss - Net Sales
Net Sales 193.73 Million
in Mar 2022

Figures in Million
stock-summary

YoY Growth in year ended Mar 2022 is 13.27% vs -2.44% in Mar 2021

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.88 Million
in Mar 2022

Figures in Million
stock-summary

YoY Growth in year ended Mar 2022 is 18.06% vs 0.15% in Mar 2021

Profit And Loss - Interest
Interest 0.00 Million
in Mar 2022

Figures in Million
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax 78.08 Million
in Mar 2022

Figures in Million
stock-summary

YoY Growth in year ended Mar 2022 is 4.16% vs 10.95% in Mar 2021